Samsung Electronics's smartphones and Google's Motorola devices gained ground among U.S. consumers in an annual satisfaction rating. Apple's iPhone is falling down and the company has been accused of tax avoidance.
Actavis will acquire Warner Chilcott in a stock-for-stock transaction worth $8.5 billion. The transaction will create a global specialty pharmaceutical company with $11 billion in combined annual revenue.
Merck Serono, a division of Merck, announced a new, five-year clinical development agreement with Quintiles, the first-of-its-kind between a biopharmaceutical company and a biopharmaceutical services provider.